104 related articles for article (PubMed ID: 29248456)
1. Endothelin-2 Injures the Blood-Retinal Barrier and Macroglial Müller Cells: Interactions with Angiotensin II, Aldosterone, and NADPH Oxidase.
Alrashdi SF; Deliyanti D; Talia DM; Wilkinson-Berka JL
Am J Pathol; 2018 Mar; 188(3):805-817. PubMed ID: 29248456
[TBL] [Abstract][Full Text] [Related]
2. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II and aldosterone activate retinal microglia.
Rana I; Suphapimol V; Jerome JR; Talia DM; Deliyanti D; Wilkinson-Berka JL
Exp Eye Res; 2020 Feb; 191():107902. PubMed ID: 31884019
[TBL] [Abstract][Full Text] [Related]
4. Protection of Glial Müller Cells by Dexamethasone in a Mouse Model of Surgically Induced Blood-Retinal Barrier Breakdown.
Siqueiros-Marquez L; Bénard R; Vacca O; Charles-Messance H; Bolaños-Jimenez R; Guilloneau X; Sennlaub F; Montañez C; Sahel JA; Rendon A; Tadayoni R; Giocanti-Aurégan A
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):876-886. PubMed ID: 28159978
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
Deliyanti D; Alrashdi SF; Tan SM; Meyer C; Ward KW; de Haan JB; Wilkinson-Berka JL
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):815-825. PubMed ID: 29411009
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats.
Alrashdi SF; Deliyanti D; Wilkinson-Berka JL
Exp Eye Res; 2018 Nov; 176():1-9. PubMed ID: 29944850
[TBL] [Abstract][Full Text] [Related]
7. Endothelin2 Induces Expression of Genes Associated with Reactive Gliosis in Retinal Müller Cells.
Sarthy VP; Sawkar H; Dudley VJ
Curr Eye Res; 2015; 40(11):1181-4. PubMed ID: 25546127
[TBL] [Abstract][Full Text] [Related]
8. Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina.
Tan SM; Deliyanti D; Figgett WA; Talia DM; de Haan JB; Wilkinson-Berka JL
Exp Eye Res; 2015 Jul; 136():1-8. PubMed ID: 25912997
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?
Binz N; Rakoczy EP; Ali Rahman IS; Vagaja NN; Lai CM
PLoS One; 2016; 11(8):e0160442. PubMed ID: 27482904
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
Ibrahim AS; Tawfik AM; Hussein KA; Elshafey S; Markand S; Rizk N; Duh EJ; Smith SB; Al-Shabrawey M
Biochim Biophys Acta; 2015 Mar; 1851(3):290-8. PubMed ID: 25562624
[TBL] [Abstract][Full Text] [Related]
11. Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation.
Kokona D; Ebneter A; Escher P; Zinkernagel MS
J Neuroinflammation; 2018 Dec; 15(1):340. PubMed ID: 30541565
[TBL] [Abstract][Full Text] [Related]
12. AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
Vacca O; Darche M; Schaffer DV; Flannery JG; Sahel JA; Rendon A; Dalkara D
Glia; 2014 Mar; 62(3):468-76. PubMed ID: 24382652
[TBL] [Abstract][Full Text] [Related]
13. AAV-mediated gene therapy in Dystrophin-Dp71 deficient mouse leads to blood-retinal barrier restoration and oedema reabsorption.
Vacca O; Charles-Messance H; El Mathari B; Sene A; Barbe P; Fouquet S; Aragón J; Darche M; Giocanti-Aurégan A; Paques M; Sahel JA; Tadayoni R; Montañez C; Dalkara D; Rendon A
Hum Mol Genet; 2016 Jul; 25(14):3070-3079. PubMed ID: 27288449
[TBL] [Abstract][Full Text] [Related]
14. Aloin Inhibits Müller Cells Swelling in a Rat Model of Thioacetamide-Induced Hepatic Retinopathy.
Jung E; Kim J
Molecules; 2018 Oct; 23(11):. PubMed ID: 30380640
[TBL] [Abstract][Full Text] [Related]
15. Retinal Macroglial Responses in Health and Disease.
de Hoz R; Rojas B; Ramírez AI; Salazar JJ; Gallego BI; Triviño A; Ramírez JM
Biomed Res Int; 2016; 2016():2954721. PubMed ID: 27294114
[TBL] [Abstract][Full Text] [Related]
16. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
17. A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.
Deliyanti D; Lee JY; Petratos S; Meyer CJ; Ward KW; Wilkinson-Berka JL; de Haan JB
Clin Sci (Lond); 2016 Aug; 130(15):1375-87. PubMed ID: 27005782
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.
Deliyanti D; Wilkinson-Berka JL
J Neuroinflammation; 2015 Jul; 12():136. PubMed ID: 26219952
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.
Wilkinson-Berka JL; Rana I; Armani R; Agrotis A
Clin Sci (Lond); 2013 May; 124(10):597-615. PubMed ID: 23379642
[TBL] [Abstract][Full Text] [Related]
20. Conditional Müller Cell Ablation Leads to Retinal Iron Accumulation.
Baumann B; Sterling J; Song Y; Song D; Fruttiger M; Gillies M; Shen W; Dunaief JL
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4223-4234. PubMed ID: 28846772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
